Skip to main content
Clinical Trials/NCT04953689
NCT04953689
Completed
Not Applicable

Technology-assisted Conscientiousness Therapy for People With Multiple Sclerosis

State University of New York at Buffalo1 site in 1 country60 target enrollmentOctober 19, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
State University of New York at Buffalo
Enrollment
60
Locations
1
Primary Endpoint
Self -Reflection and Insight Scale (SRIS): change from baseline to 12 weeks and from baseline to 24 weeks
Status
Completed
Last Updated
last year

Overview

Brief Summary

This is a validation study of a conscientiousness-based phone app intervention strategy to help people with their health management and employment.

Detailed Description

The primary objective is to establish whether people with MS with low Conscientiousness benefit from a cognitive-behavioral, phone app intervention. Also enrolled are healthy individuals over the age of 60. This group's response to the intervention will be compared to the MS sample. The investigators also aim to determine the acceptability and utilization of the Conscientiousness-Coach phone application and intervention. It is anticipated that the Conscientiousness-Coach phone app intervention will result in fewer negative work events and increased work accommodations in those treated, relative to the control group. In exploration of other secondary outcomes, the investigators also expect that the treatment will result in increased self-report trait Conscientiousness itself, increase in structured leisure activities, reduction in depression, and reduction in anxiety. This is a prospective longitudinal design with an experimental manipulation (i.e., a randomized-controlled trial). There will be an initial assessment with neuropsychological testing, the Buffalo Vocational Monitoring Survey (BVMS), and several self-report measures, and a post-test assessment after three months and six months with these same instruments, excluding the neuropsychological assessment. The BVMS will also be administered at 0 months, 3 months, and 6 months to further assess post-treatment effects.

Registry
clinicaltrials.gov
Start Date
October 19, 2021
End Date
October 28, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ralph H.B. Benedict

Professor

State University of New York at Buffalo

Eligibility Criteria

Inclusion Criteria

  • Has a diagnosis of Multiple Sclerosis or is over 60 years of age.
  • If an MS patient: is above 18 years of age.
  • No history of substance dependence/abuse, psychiatric disorders, or any neurological disease other than MS
  • If an MS patient: has a NEO-FFI Conscientiousness score that is one standard deviation or more below the healthy adult mean (t=40)

Exclusion Criteria

  • Does not meet one or more of the above inclusion criteria

Outcomes

Primary Outcomes

Self -Reflection and Insight Scale (SRIS): change from baseline to 12 weeks and from baseline to 24 weeks

Time Frame: At baseline, Week 12, and Week 24.

20 question self-report measure which assesses participants private self-consciousness using self-reflection and insight components. Total score of 20-120 points is calculated, with higher scores indicating greater self-reflection and insight.

Buffalo Vocational Monitoring Survey (BVMS): change from baseline to 12 weeks and from baseline to 24 weeks

Time Frame: At baseline, Week 12, and Week 24

Assesses general employment information (e.g. number of hours worked per week, job title, and income) and work-related problems and accommodations. Participants will identify specific negative work events (e.g. formal reprimand) experienced in the past 3 months and provide a list of job accommodations to endorse if they are receiving them at the time of survey. Income, number of hours worked per week, number of negative work events (0 to 7, with higher number indicating more negative work events), and number of accommodations (0 to 40, with higher number indicating more accommodations) will be used as outcomes from this survey.

The Valued Living Questionnaire (VLQ): change from baseline to 12 weeks and from baseline to 24 weeks

Time Frame: At baseline, Week 12, and Week 24

Assesses valued living, or the extent to which an individual contacts his or her chosen values in everyday life. Respondents are asked to rate the 10 areas of life on a scale of 1-10, indicating the level of importance and how consistently they have lived in accord with those values in the past week. The composite score is used (1-100 points), with higher scores indicating a greater extent to which one is living out particular values in everyday life.

Secondary Outcomes

  • NEO Five Factor Inventory (NEOFFI): change from baseline to 12 weeks and from baseline to 24 weeks(At baseline, Week 12, and Week 24.)
  • Beck Anxiety Inventory (BAI): change from baseline to 12 weeks and from baseline to 24 weeks(At baseline, Week 12, and Week 24.)
  • Beck Depression Inventory 2nd Edition (BDI-II): change from baseline to 12 weeks and from baseline to 24 weeks(At baseline, Week 12, and Week 24.)
  • The Brief Visuospatial Memory Test Revised (BVMTR)(At baseline only)
  • The California Verbal Learning Test Second Edition (CVLT2)(At baseline only)
  • The Symbol Digit Modalities Test (SDMT)(At baseline only)
  • Quality of Life in Neurological Disorders (NeuroQol): change from baseline to 12 weeks and from baseline to 24 weeks(At baseline, Week 12, and Week 24.)
  • Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23): change from baseline to 12 weeks and from baseline to 24 weeks(At baseline, Week 12, and Week 24.)

Study Sites (1)

Loading locations...

Similar Trials